Nanoform

Global experts in nanotechnology and drug particle engineering

[Nanoform @NanoformF]

Nanoencorafenib Value Proposition! 6 capsules to a single tablet

[Nanoform @NanoformF]

Nanoform partners with two specialist healthcare investors to develop and commercialize Nanoencorafenib: https://t.co/nKBPLZshoL
Nanoform Q1 2025 report: Deal mosaic emerge and commercial value clearly seen in our CESS® technology: https://t.co/dBmmvz7cr1

[Nanoform @NanoformF]

Please tune into our audio webcast presentation today at 15.00 EEST: https://t.co/oE7LrkBFQ2

[Nanoform @NanoformF]

Now in its 14th year, the Outsourced Pharma CDMO Leadership Awards celebrated and recognised innovation and excellence in quality and delivery across the sector and we extend our sincere thanks to the jury!

[Nanoform @NanoformF]

Last night in New York, Nanoform celebrated in winning the inaugural prize for ‘𝐌𝐨𝐬𝐭 𝐏𝐫𝐨𝐦𝐢𝐬𝐢𝐧𝐠 𝐍𝐞𝐰 𝐃𝐫𝐮𝐠 𝐃𝐞𝐥𝐢𝐯𝐞𝐫𝐲 𝐓𝐞𝐜𝐡𝐧𝐨𝐥𝐨𝐠𝐲 𝐂𝐨𝐦𝐩𝐚𝐧𝐲’, which recognized the highest-scoring company in the category as voted for by industry professionals.

[Nanoform @NanoformF]

We are honored for Nanoform to be recognized as we partner with top industry innovators towards bringing nanoimproved products to patients soon!

[Nanoform @NanoformF]

Join Nanoform at DCAT Week 2025!
Nanoform team - Christian Jones, Sergie Letser, Rob Sterling and Chris Worrall - will be attending DCAT Week in New York!
To arrange a meeting, reach out to us at [email protected]
#Nanoform #NanoImprove #smallispowerful #DCATWeek

[Nanoform @NanoformF]

A special thank you to Dr Makarand Jawadekar and Dr. Ajit Shetty for their support in the preparations!

And a big thank you to the organizers of #BioAsia2025 for an inspiring event!

[Nanoform @NanoformF]

Christian Jones attended @BioAsiaOfficial 2025 this week, Asia's largest Life Sciences & Healthtech convention, held in Hyderabad, India.

[Nanoform @NanoformF]

During the event, he participated in a highly engaging panel on accelerating innovative medicines for the benefit of patients, sharing Nanoform’s perspective on driving pharmaceutical innovation forward.

[Nanoform @NanoformF]

Nanoform Q4 report is out! 2024 showed a record number of customer projects signed and revenue growth is back.
Please tune into our webcast presentation at 15.00 Helsinki time: https://t.co/4PkymHzUME
Please read the full Press Release here: https://t.co/Whlq543QPN

[Nanoform @NanoformF]

𝐒𝐩𝐨𝐭𝐥𝐢𝐠𝐡𝐭 𝐨𝐧 𝐍𝐚𝐧𝐨𝐟𝐨𝐫𝐦'𝐬 𝐌𝐚𝐧𝐮𝐟𝐚𝐜𝐭𝐮𝐫𝐢𝐧𝐠 𝐂𝐚𝐩𝐚𝐛𝐢𝐥𝐢𝐭𝐢𝐞𝐬
Our latest video showcases Nanoform’s state-of-the-art manufacturing capabilities, led by our Head of Manufacturing, Dr David Rowe.

Watch the video: 👇
https://t.co/h9Qa0LTTn7

[Nanoform @NanoformF]

In case you missed it, Nanoform’s Chief Commercial Officer Christian Jones, gave an insightful overview at #CPHI Milan, exploring how Nanoform’s cutting-edge capabilities are addressing industry trends and driving innovation.
Watch the recap! 👇
https://t.co/5UDVYhFcwZ

[Nanoform @NanoformF]

This week, we welcomed Jan Brummund, our new Business Development Director, Europe. It was great to have Jan on site and introduce the team!

We’re thrilled to have you on board, Jan - welcome to the team!

[Nanoform @NanoformF]

Meet the Nanoform Team at J.P. Morgan 2025!
From January 13th - 16th, our team will be attending the J.P. Morgan Healthcare Conference in San Francisco.

Don’t miss the opportunity to connect! Reach out to arrange a meeting!
👉 [email protected]

#NanoImprove #JPM25

[Nanoform @NanoformF]

🎄 𝐇𝐚𝐩𝐩𝐲 𝐡𝐨𝐥𝐢𝐝𝐚𝐲𝐬 𝐟𝐫𝐨𝐦 𝐍𝐚𝐧𝐨𝐟𝐨𝐫𝐦! 🎄

May your holidays be filled with joy, and may the new year bring you health, success, and exciting opportunities!

[Nanoform @NanoformF]

Wishing a Happy Thanksgiving to our US colleagues and partners!

[Nanoform @NanoformF]

📍 On the road with Nanoform's leaders!

Today, CEO Edward Hæggström, CFO Albert Haeggström, & IR Director Henri von Haartman are at SEB Healthcare Seminar 2024 in Stockholm, hosted by Christopher Uhde, presenting our innovations & meeting investors.

[Nanoform @NanoformF]

Nanoform online presentation and conference call November 18, 2024, at 3:00 p.m. Helsinki time / 2:00 p.m. Stockholm time.
The presentation will be broadcast live as a webcast available at:
https://t.co/vEL8PHyu4C

[Nanoform @NanoformF]

@NanoformF Q3 2024 report - Record number of new non-GMP projects signed in the quarter. Revenue growth is back and is expected to accelerate in coming quarters and years.
Please read the full Press Release here: https://t.co/qnD5tNIOrv